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Several studies have shown that erythrocyte sodium lithium 
countertransport (SLC) activity to be elevated in patients with 
essential hypertension, those with a family history of 
hypertension and in normotensive first degree relatives of 
hypertensives. Studies on erythrocytes SLC activity in established 
pregnancy-induced hypertension (PIH) have failed to show any 
difference between mean values in subjects with pregnancy-
induced hypertension and those with normotensive pregnancy. The 
reasons for this is not known. It is possible that changes in SLC 
activity in later pregnancy, when signs of PIH are established, 
may obscure any hereditary predisposition for developing the 
condition. 
Identification of high risk pregnant subjects at their early 
stage of pregnancy, if feasible, would be helpful in the care and 
management. It would also save a considerable sum of designated 
health expenditure which could be used for other purposes. Many 
methods of prediction have been tested but none has been proved 
to be of practical use to date. 
The precision for the determination of erythrocyte SLC was 
found to be about 6%. SLC was measured in 10 healthy non-
pregnant women in the proliferative and secretory phases of the 
menstrual cycle to determine the effect of hormonal changes on 
SLC: no statistical difference of SLC activity was found. Intra-
individual variation of SLC was assessed on 5 healthy men at 
varied spans of time up to 28 weeks: no significant change was 
observed over this time period showing that SLC is a very stable 
biochemical in dex. 
In this study, SLC activity has been measured in a group 
of more than a hundred primigravid Chinese subjects in the 
second and third trimesters of pregnancy to evaluate its 
predictive value for PIH. The erythrocyte SLC was determined in 
sixty three subjects in the second trimester and in ninety 
subjects in the third trimester. Of these, thirteen subjects in the 
second trimester, and twelve subjects in the third trimester 
subsequently developed PIH. There was no significant difference 
in the erythrocyte SLC activity in the subjects who developed 
hypertension compared to those who remained normotensive. In 
normotensive and those with PIH, erythrocyte SLC increased with 
increasing gestational age. However, the rate of rise of 
erythrocyte SLC was not significantly different between the two 
groups of subjects. Erythrocyte SLC activity has no value as a 
predictor of PIH in either second or third trimesters of 
pregnancy. 
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1.1 PREGNANCY-INDUCED HYPERTENSION 
a. Definitions and Classifications 
Hypertensive disorders of pregnancy, formerly referred to 
as "Toxaemia of pregnancy", include several diseases and 
syndromes associated with high blood pressure. In this section 
the definition and classification of pregnancy-ind uced 
hypertension will be considered. 
What is pregnancy-induced hypertension (PIH)? In the 
English and German literature alone, more than 100 names have 
been used to describe the different hypertensive diseases of 
pregnancy and there have been almost as many classifications 
(Rippman, 1969). Inappropriate terms such as "Toxaemia of 
pregnancy" are now obsolete. It has been postulated for many 
years that toxin are released from the pregnant uterus, however 
all efforts have so far failed to demonstrate any such toxin (Lewis 
& Chamberlain, 1990). It is certain that definitions of PIH have 
never been satisfactory. Pregnancy-induced hypertension simply 
cannot be defined unerringly until its cause is known. In recent 
years, the definitions and classification set up by the American 
College of Obstetricians and Gynecologists, or the revised 
definitions put forward by Redman & Jefferies are being more 
extensively used (Nelson, 1955; Redman & Jefferies, 1988). 
Promulgated by Nelson, the customary British definition which has 
once been widely used in the commonwealth nations and some 
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other parts of the world, is now less frequently being quoted. Dr. 
C.W.G. Redman has quoted, " There is a probable bias in the 
Nelson definition towards including women with mild chronic 
hypertension." (Redman & Jefferies, 1988). In Nelson's definition, 
a Pre-eclamptic has a threshold diastolic pressure of or above 90 
mmHg after midpregnancy, however the magnitude of the 
increment is not specified. Hence mild chronic hypertensives with 
their higher baseline blood pressures can easily be included with 
the bona fide pre-eclamptics, as diastolic pressure usually rises 
by more than 10 mmHg in late pregnancy (MacGillivray et aI, 
1969). 
Although it is controversial, today, to many clinicians, pre-
eclampsia is merely another appellation for PIH (Brown, 1989; 
Hargood & Brown, 1990); in fact, the term 'pre-eclampsia' has been 
criticized because of the small number of the patients that 
ultimately develop eclampsia (Lewis & Chamberlain, 1990). 
Eclampsia may be the outcome of PIH when the latter is neglected 
or, less often, simply occurs in fulminant cases. The convulsions 
of eclampsia are grand mal in type and may first appear before 
labour, during labour, or postpartum (Hibbard, 1988). 
PIH is, according to the revised definition, the development 
of a diastolic blood pressure (phase IV) greater than 90 mmHg 
after twenty weeks' gestation in a primigravid subject with no 
prior hypertension or renal disease and where the blood pressure 
returns to normal post partum. This diagnosis is most certain if 
these features are accompanied by an early diastolic pressure less 
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than 90 mmHg and a subsequent rise of more than 25 mmHg from 
this level. (Redman & Jefferies 1988; MacGillivray 1983). Thus both 
pre-eclampsia and cases formerly described as gestational 
hypertension are included in pregnancy-induced hypertension. 
b. Proteinuria 
Some authors have incorporated proteinuria in the definition 
of pre-eclampsia (Macgillivray, 1983; Redman & Jefferies, 1988). i.e. 
pregnancy-induced hypertension with significant proteinuria. In 
two prospective studies involving over 10,000 subjects, it was 
found that perinatal mortality was inversely proportional to the 
degree of proteinuria (Page & Christianson, 1976; Naeye & 
Friedman, 1979). Both studies used random urine specimens and 
must be criticised accordingly; a more precise quantification using 
24 hour urine collection is desirable. 
c. Oedema 
Oedema was first regarded to be one of the diagnostic signs 
of pre-eclampsia (Nelson, 1955). However, in a prospective study 
involving 83 pregnant subjects, moderate oedema was found in 
80% of normotensive pregnancies (Robertson, 1971). In a large 
study involving over 4,000 patients, it was found that pressure 




Some studies have suggested that elevated plasma urate is 
a specific diagnostic feature of pre-eclampsia (Redman et ai., 1976; 
Rubin, 1988). In a study involving 332 hypertensive pregnant 
patients, plasma urate levels proved a better indicator of fetal 
prognosis than blood pressure. Since uric acid is filtered through 
the glomeruli, elevated plasma urate levels are probably better 
regarded not as diagnostic or specific feature of pre-eclampsia, 
but as a sensitive indicator of impaired renal function and renal 
blood flow. 
1.2 A BRIEF HISTORY OF PREGNANCY-INDUCED HYPERTENSION 
Eclampsia was almost synonymous with epilepsy before 1739. 
In that year, de Sauvages attributed all convulsions of acute 
causation to "eclampsia", while epilepsy was an ailment, with 
recurring convulsions through the years. Little more was known 
about eclampsia until, in 1843, Lever, a Irish novelist, whilst 
working as a dispensary physician in Guy's Hospital (before his 
book was published and made him famous) had discovered that 
many of the women who had convulsions also had albumin in their 
urine. Simpson made a similar discovery in the same year 
(Chesley, 1984). The introduction of the sphygmomanometer early 
this century had allowed recognition that eclampsia was associated 
with hypertension. It is very likely that "eclampsia" was also 
known to the ancient Egyptians, Chinese, an'd Indians (Chesley 
1978; Lewis & Chamberlain 1990). 
6 
1.3 EPIDEMIOLOGY OF PREGNANCY-INDUCED HYPERTENSION 
Due to differences in the populations studied and the 
diagnostic criteria adopted, the incidence of pregnancy-induced 
hypertension varies widely. It is high in places such as Australia, 
affecting 15 percent of the total primigravid pregnant women 
(Brown, 1989) and relatively low in areas such as Hong Kong 
where its incidence is usually cited to be between 5 and 10 
percent (Chun & Lee, 1990). In the united States, data from the 
National Hospital Discharge Survey during the period 1979 to 1986, 
concluded that the average annual incidence of pre-eclampsia was 
2.6 percent (Saftlas et aI, 1990). It is apparent that any sort of 
comparison based on geographic distribution of pregnancy-
induced hypertension is unlikely to be rewarding. Davies, after 
evaluating not less than 170 papers collected from 50 nations, 
wrote " ... the vast majority of the reports in the literature are 
not representative of the populations studied and because of 
variations in classification, the absence of data on age and parity 
structure and so forth, cannot be used for any international 
comparison, even of the grossest sort" (Davies, 1971). 
Pregnancy-induced hypertension most often affects 
nulliparous women (Baird, 1977; Campbell et aI, 1985). It is more 
common in women over 35, particularly in those relatively infertile 
primigravidae (Lewis & Chamberlain, 1990). Young teenage 
primigravid women are also at appreciably greater risk for 
preeclampsia (Cunningham et aI, 1989; Saftlas et aI, 1990). To 
generalize: pregnancy-induced hypertension is most commonly 
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encountered in primigravidae at the extremes of reproductive age. 
Pre-eclampsia appears to be more frequent in obese women, a 
pregnant woman having abnormal weight gain may be developing 
hypertensive disease, or , may just have had an excessive 
carbohydrate intake which should be discouraged (Treharne, 1984; 
Lewis & Chamberlain, 1990). In normal pregnancies, there is an 
average weight gain of about 12 kg. Because of nausea and 
vomiting, a loss of weight can occur in some women in the first 
trimester. On average a gain of about 0.5 kg per week from the 
12th week till term is observed. However, there is frequently a 
loss of more or less 0.5 kg in the week before delivery. The 
weight of the foetus, placenta and liq uor amnii, increased blood 
volume and extracellular fluid, the increase in size of the uterus 
and breasts, and fat deposition all contribute to the total weight 
gained in pregnancy. In addition, in pregnancy-induced 
hypertension, there is often, but not always, an increase in salt 
and water retention in the extracellular space (Treharne, 1984). 
Multiple pregnancies may increase the incidence of 
pregnancy-induced hypertension. Not even the relative immunity 
of a multipara prevents her from developing preeclampsia, if she 
has a multiple gestation. A good example of this is that of Mrs. 
Dionne, she was in her eighth pregnancy when she bore her 
famous quintuplets. She is said to have had severe, almost lethal 
preeclampsia (Chesley, 1984). 
There is also an increased incidence of PIH in association 
with hydatidiform mole and diabetes mellitus. These associations 
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are of considerable interest. In hydatidiform mole, the 
hypertension is frequently severe, occurring early in pregnancy, 
and in the absence of a foetus. On the other hand, babies born 
to diabetic mothers are frequently macrosomic. Sundry papers 
have confirmed the high incidence of hypertensive disorders in 
pregnant diabetic women, with combined incidences and 
prevalences as high as 50% (Chesley, 1984). A recent report from 
Canada concludes that Pre-eclampsia is twice as common in 
diabetic pregnancies compared with normal controls (Garner et aI., 
1990). Hydatidiform mole and Diabetes mellitus in pregnancy, as 
well as multiple pregnancy, are not infrequently associated with 
large placentae: the term "hyperplacentosis" has thus often been 
used (Lewis & Chamberlain, 1990). 
An increased incidence of pregnancy-induced hypertension 
in association with severe rhesus incompatibility, with 
polyhydramnios, with triploidy, and with erythroblastosis fetalis 
has also been reported (Simpson, 1989; Lewis & Chamberlain , 
1990). 
Socio-economic status does not seem to have strong 
relationship with preeclampsia. According to Nelson, who had 
examined the details of nearly all gestations and deliveries in 
Aberdeen, Scotland, found that the incidence of Preeclampsia was 
basically similar in 'each of the five social classes, rangin g from 
the professional to unskilled workers (Chesley, 1984). 
1.4 PREDICTION OF PREGNANCY-INDUCED HYPERTENSION 
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It is an ideal that disease can be predicted before the 
onset of signs and symptoms so that any preventative measures 
can be instituted as early as possible. Thus, if PIR could be 
prevented, its associated morbidity and mortality could be 
reduced. Worley (1984) recommended a management plan of rest, 
regular out-patient attendance, and early hospitalisation aimed at 
those patients who are at an increased ris k of developing PIR. 
Nakamura et al (1986) advocated a low salt diet for such patients. 
Recent studies have suggested prophylactic benefits to both low-
dose aspirin (Beaufils et aI, 1985) and fish oil administration 
(Secher & Olsen, 1990). The difficulty is in differentiating between 
those who are and will remain normal, those who appear normal 
but will later develop PIR. To this end there are several tests 
that have been advocated to be of use in the prediction of PIR. 
a. The angiotensin sensitivity test 
Gant el al (1973) first reported that infusion of angiotensin 
11 to primigravid women distinguished those who developed PIR 
at a later stage of the same pregnancy. They studied 192 Afro-
American subjects aged between 13-17 years of age and found 
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that those who developed PIR at a later stage, showed an 
increased vascular sensitivity to angiotensin 11 as early as the 18 
to 22 weeks of pregnancy_ Subsequent studies however, have 
found substantial false positive rates (Oney & Kaulhausen, 1982; 
Nakamura et aI, 1986). Although, this test ,is regarded as the most 
discriminatory test available, it is a time consuming procedure 
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requiring the placement of a intrav enous cannula a nd th e 
presence of a clinician throughout, thus renderin g it unsuit i ble 
for screening the general population. 
b. The roll-over test 
The roll-over test was first described by Gant and co-
workers in 1974. They reported that an increase of >20 mmH g in 
diastolic blood pressure, when the patient was turned from the 
left lateral to the supine position, predicted the development of 
subsequent hypertension in 15 out of 16 women tested between 28 
and 32 weeks of gestation. However, subsequent studies have 
indicated that this test is less satisfactory with false negative 
rates of 19% and a false positive rate of 90% (Turnbridge & 
Donnai, 1983; Dekker et aI., 1990). Although this test is easy to 
perform and requires only time and personnel, rather than 
expenSlve equipment, it has found little place in obstetric 
practice. 
c. Mid-trimester blood pressure measurements 
The use of mid-trimester blood pressure blood pressure as 
predictive test for PIH was proposed by Page & Christianson 
(1976). In this study, 14,833 women of mixed parity during the 
fifth and sixth months of gestation were studied. They expressed 
blood pressure as mean arterial pressure (MAP: the diastolic 
pressure plus one third of the pulse pressure). There was a 
steady progression in the incidence of the disease (defined as 
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MAP>110 mmHg) with each 5 mmHg increment in mid-trimester MAP. 
A mid trimester MAP> 90 mmRg increased the risk of development 
by over three-fold (Page & Christianson, 1976). Several 
subsequent studies have however, revealed a wide disparity in 
the predictive values of the test, with sensitivities of 8-71% and 
positive predictive values of 14-23% (Baker, 1993). 
d. Forearm venous tone 
Stainer and co-workers found that women with PIR were 
vasoconstricted in the forearm, when compared to normotensive 
women (1986) and suggested that measurement of venous tone may 
have potential as a screening test for PIR. However, the number 
of subjects studied was small (only 11 PIR patients). A 
prospective study by the same group demonstrated similar results 
(Stainar et aI., 1986). This method is quite time-consurning, and 
requires both temperature control and sophisticated instruments. 
e. Doppler ultrasound 
Doppler ultrasound scanning is becoming an increasingly 
controversial technique (see review, Neilson, 1987), and detailed 
discussion on this technique is beyond the scope of this thesis. 
Campbell and co-workers studied 126 women at 16-18 weeks of 
pregnancy and found a higher incidence of PIR developing in 
women with abnormal waveforms. The very high incidence (40%) 
of abnormal waveforms demonstrated in this series may be 
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spurious (Campbell et aI., 1986). A subsequent study of Doppler 
uteroplacental waveforms in untreated cases of PIH, demonstrated 
no difference from the normotensive controls (Hanretty et aI, 
1988). The value of this technique as a screening procedure is 
thus unproven. 
f. Plasma urate measurements 
Redman and co-workers suggested that serial measurements 
of plasma urate were useful in predicting the subjects who 
develop PIH (Redman et aI., 1976). However, plasma urate levels 
were found to be elevated in 58% of patients with essential 
hypertension under treatment (Breckenridge, 1966). Since uric 
acid is filtered through the glomeruli, this test is probably an 
indicator of impaired renal function and renal blood flow. 
g. Plasma fibronectin measurements 
Plasma concentrations of fibronectin were measured in 33 
preeclamptic and 36 control patients at varying gestational ages 
by Lockwood and Peters (1990). They found that significant 
elevations in circulating concentrations of fibronectin with an 
extra type III domain compared to control patients (Lockwood and 
Peters, 1990). These data are very promising but to test the 
efficacy of using it as predictive test, further work is required. 
h. Urine albumin and calcium excretion 
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Lopez-Espinosa et al (1986) studied urinary albumin 
excretion in a group of mixed parity women and found that 
protein uric PIH was not preceded by a phase of increasing 
albumin loss. Rodriguez and co workers (1988) evaluated the value 
of urinary albumin and calcium/ creatinine ratio as predictive 
tests. They studied 88 normotensive women of mixed parity at 24-
34 weeks of gestation, using values of <0.04 ug/ml and >11 ug /ml 
as positive test results for the calcium/ creatinine and albumin 
values , respectively. The calcium/creatinine ratio outperformed 
measurements of microalbuminuria, with a false positive rate of 
36% and a false positive rate of 4 %. Although these results 
looked promising, the high proportion of multiparous women in 
this group who developed PIR led to authors to suggest that 
further work is required involving primigravid subjects for 
confirmation (Rodriguez et aI, 1986). 
i. Platelet angiotensin 11 binding assay 
This is relatively easy test to perform requiring only 20 ml 
of blood. In normotensive primigravidae, platelet angiotensin 11 
binding falls between 5-8 weeks of gestation. In contrast, 
significantly higher levels are found in women with established 
pre-eclampsia as compared to normotensive primigravidae (Baker 
et aI., 1992). Moreover, the difference in platelet angiotensin 11 
binding was found to be more effective in predicting the outcome 
of pregnancies than the angiotensin 11 sensitivity test (Baker et 
aI., 1991). In addition, there is a significant correlation between 
the values of platelet angiotensin 11 binding and the slope of the 
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curve relating to the diastolic pressor response to infused 
angiotensin 11, suggesting that collinearity between the two 
tech niq ues exist (Baker et aI., 1991). 
At present, none of the above techniques are suitable for 
screening large numbers of subjects, except perhaps the recently 
reported platelet angiotensin 11 binding assay , in order to select 
those at risk of developing PIH. 
1.5 ERYTHROCYTE SODIUM-LITHIUM COUNTERTRANSPORT (SLC) 
1.5.1 HISTORY AND CHARACTERISTICS OF SLC 
Lithium (Li) was occasionally used in the 19th century for 
gou t, for sedation and against epilepsy. During chronic Li 
administration in manic patients, the Li concentration in the 
erythrocytes was observed to be considerably lower than that in 
the plasma, with a ratio of about 1:3 (Frazer et aI., 1973; 
Zakowska-Dabowska et aI., 1973). Since Li was not bound to 
plasma proteins, researchers began to suggest that Li was 
transported out of the erythrocyte against an electrochemical 
gradient (Gershon, 1970). 
It was Ussing in 1949 who first suggested the existence of 
an electroneutral carrier within a plasma membrane (Ussing, 1949). 
Eleven years later, in 1960, Tosteson an d Hoffman hypothesized 
that Li could move through the red cell membrane via an ouabain-
insensitive process of Li-Na exchange diffusion (Tosteson & 
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Hoffrnan, 1960). It was not until the mid 70's, when this ouabain-
insensitive transport mechanism was finally demonstrated 
independently by two research groups (Haas et ai., 1975; Duhm et 
ai., 1976). In their experiments on human erythrocytes where Na 
was replaced by Li in the cytoplasm, indirect evidence of an 
electroneutral carrier performing Na-Na transInembrane exchange 
by facilitated diffusion with 1: 1 stoichiometry was obtained. 
The sodium-lithium countertransport system has been shown 
to display saturation kinetics. The concentrations of internal Li 
and Na required to produce half-maximal exchange are about 0.5 
mmol/L and 9.0 mmol/L respectively, indicating that the affinity 
of the system is about 20 times greater for Li than for Na. The 
Km for external Li and Na are 1.5 mmol/L and 25 mmol/L 
respectively (Pandey et ai., 1978; Sarkadi et ai., 1978). However, 
Rutherford and colleagues has found a very different external Km 
for sodium. In a group of 17 normal subjects, it is in the range 
95-270 mmol/L (Rutherford et ai., 1990). Although no conclusive 
understanding of what an external Km for sodium in SLC is, at 
least in some individuals, it can be as high as 100-250 mmol/L. 
Individual variation in Li efflux is due to differences in the 
maximum rate of transport (V max) but not Li's affinity for the 
transport mechanism (Duhm & Becker, 1977b). SLC differences 
amongst species also arised from a variation in Vmax• Experiments 
show that in bovine -red cells, the Km for Li is similar to the value 
measured in human erythrocytes, however, the Vmax in bovine red 
cells is much greater (Funder & Wieth, 1978). 
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Showing a similar profile to sodium-sodiurn exchange, SLC 
is sensitive to pH (Duhm & Becker; 1979). Maximal activity has 
been observed at just over pH 8 and drops rapidly below 
physiological pH. SLC is also shown to be affected markedly by 
temperature, activity declines rapidly below 37° C (Smith et ai. , 
1982). 
An intricate controversy about whether Na-Li 
countertransport and Na-H antiporter are mediated by the same 
transporter has long existed. The latter operates physiologically 
to maintain intracellular pH, cell volume and boost Na influx 
(Mahnensmith & Aronson, 1985). Studies by Canessa et al. have 
recommended that the two exchanges are mediated by the same 
transporter (Canessa et ai., 1987). The discovery of an apparently 
specific inhibitor of sodium-lithium exchange, called inhibitin, has 
added more weight to this proposition (Morgan et ai., 1989). 
However unlike Na-H exchange in most systems, RBC Li-Na 
countertransport is not fully amiloride-sensitive (Escobales & 
Canessa 1986; Kahn, 1987). 
Five mechanisms are involved in the transport of lithium 
across the human red blood cell membrane. 
1. The active sodium-potassium transport system 
At low extracellular potassium concentration, active lithium 
influx can be observed; in the absence of intracellular sodium, 
active lithium efflux can be seen. In other words, at physiological 
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concentrations of plasma K and cell Na, no Li is transported by 
this active pump. Ouabain in hibits both types of lithium transport 
cODlpletely (Sarkadi et aI., 1978). 
2. The anion exchange system 
In bicarbonate containing media, lithium transport across 
the red cell membrane is increased (Wieth, 1970). This increased 
passive lithium flux is attributed to transport of negatively 
charged carbonate ion pairs by way of the physiologically 
important chloride-carbonate exchange system of the erythrocyte 
membrane. This transport does not occur in bicarbonate-free NaCI 
or KCI media; it is passive and downhill, and is blocked completely 
by specific inhibitors of anion transport (Funder et aI, 1978). 
3. The sodium-potassium cotransport system 
Evidence suggests that Li can cross the red cell membrane 
together with K by a passive system that normally carries K and 
Na simultaneously in the same direction. However in cells 
containing sodium, and at relatively low intracellular lithium 
concentrations, this mode of transportation is not significant 
(Canessa et aI. , 1980). Diuretics such as furosemide a nd 
bumetanide inhibit this cotransport (Wiley & Cooper, 1974). 
4. The sodium-sodium exchange system 
As mentioned, this transport process is a tightly coupled 
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exchange mechanism, coupling the efflux of one cation to the 
influx of another. However only sodium and lithium are involved 
in this process. Since lithium behaves like sodium, it is also called 
the sodium-lithium countertransport. The system is ouabain and 
oligomycin insensitive, but phloretin, furosemide, quinine, and 
quinidine sensitive, and is inhibited by removing exchangeable 
cations from the trans-side of the membrane. It is also sensitive 
to the thiol-alkylating agent N-ethylmalemide, but only a 50% 
inhibition can be obtained with this agent (Duhm & Becker; 1979) . 
Under physiological conditions the plasma Na is 14-15 times higher 
than the cell Na, thus Li tends to be transported out of the cell 
against its electrochemical gradient in exchange for Na, which 
moves into the cell down its gradient. This transport process does 
not require the presence of cellular ATP. The energy that stoke 
up the active extrusion of Li derives from the activity of the 
ATP-dependent Na-K pump which results in at first the 
disequilibrium of Na across the membrane. Under normal 
circumstances, the sodium-lithium countertransport system does 
not transport Li, because the ion is present only in trace amount 
in vivo. 
5. Electrodiffusion (The lithium leak) 
This is a residual flux of lithium, and is proportional to the 
lithium concentration gradient across the membrane. The four 
preceding transport systems do not have a direct effect on this 
diffusional flux. No known inhibitor can block this pathway of 
lithium transport (Sarkadi et ai, 1978). 
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1.5.2 SLC IN ESSENTIAL HYPERTENSION 
Canessa et al reported in 1980 that sodium-lithium 
countertransport activity was greater in patients with essential 
hypertension [0.55±0.02(mean±SEM) mmol/hr/L rbc] than in control 
subjects (0.24±0.02) (Canessa et aI., 1980). They also found no sex 
difference amongst normotensive subjects. However, am'ongst the 
hypertensive patients, SLC was greater in men than in women. As 
the latter group consist only of nine hypertensive women in their 
study, they suggested that its validity should be confirnled in a 
larger sample. They also suggested that the relationship of 
elevated erythrocyte SLC to the pathogenesis of essential 
hypertension is a reflection of an abnormality in sodium transport 
in vascular smooth-muscle cells which is somehow coupled to 
contraction and increased vascular resistance. For the cause of 
the increased maximum rate of erythrocyte SLC in patients with 
essential hypertension, they believe it could be due to an 
increase in the surface density or turnover rate, or both, of the 
transport sites, and all these are likely to be gene-determined 
(Canessa et aI., 1980). 
Canessa et al found that SLC was greater than 0.4 
mmol/hr/L rbc in almost all of the patients with essential 
hypertension compared to all normotensive controls (Canessa et 
aI., 1980). However, in some subsequent studies done by different 
groups, results did not show a clear distinction between essential 
hypertension and normotension as the pioneering study did (Clegg 
et aI., 1982; Hunt et aI., 1986; Weder, 1991). 
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Canali et al found that red cell SLC is increased in 
hypertensives but with a significant overlap with values found in 
normotensive controls. SLC was higher only in hypertensives with 
at least one hypertensive first-degree relative. They concluded 
that " the increase of SLC in erythrocytes is not a consistent 
marker of essential hypertension. It seems to be associated with 
the family prevalence and/or the hereditability of hypertension, 
rather than with high blood pressure per se." (Canali et al., 1981) 
Cusi and colleagues reported a significantly higher SLC in 
the hypertensive patients than in the normotensive controls 
without a family history of hypertension. However, they observed 
a greater overlap between individual values. They also observed 
that the offspring of hypertensive parents had intermediate 
values. In nine hypertensive families studied, if a change of the 
transport system was detected in a hypertensive subject, the 
same type of alteration was also found in his still normotensive 
descendants, confirming a familial tendency for the alteration to 
take place. The increased SLC was not related to sodium 
consumption, since the latter was similar in both su bjects with 
either high or low SLC (Cusi et aI., 1981). 
Clegg et al (1982) measured the SLC and sodium content of 
red cells in 75 patients with untreated essential hypertension. 
They found the average values of both were higher than those of 
normotensive contr.ols, and only patients with a family history of 
hypertension had values above the range in the controls. From 
the differenc~s and correlations ·of the results, they divided their 
2 1 
patients into four subgroups. Patients in group 0 had no farnily 
history of hypertension and values for SLC and red cell sodium 
were normal. Patients In group 1 had a family history of 
hypertension but normal SLC and red cell sodium content. 
Patients in group 2 and 3 had raised SLC and a family history of 
hypertension , but those in group 2 had normal red cell sodiunl 
content but whereas those in group 3, had a raised sodium 
content. They suggested that essential hypertension was a 
heterogenous disease. (Clegg et aI., 1982). 
Postnov and associates demonstrated that erythrocyte SLC 
could be used in distinguishing those who had essential 
hypertension from normotensive controls and those who had 
pheochromocytoma, Itsenko-Cushing disease, and Conn's syndrome. 
Compared to normotensives, the hypertensives demonstrated a 
more than 60% increase in SLC. In patients with 
pheochromocytoma, SLC was around 40% of the value in control 
patients. They did not detect any changes of SLC in patients with 
renal hypertension, Itsenko-Cushing disease and Conn's syndrome 
(Postnov et aI. , 1985). 
There is some evidence which suggests a renal abnormality 
precedes the development of hypertension. Weder demonstrated 
that hypertensive patients have increased proximal tubular 
reabsorption of Na and thus have a lower renal Li clearance than 
normotensive subjects and, that enhanced proximal tubular Na 
reabsorption may precede the development of essential 
hypertension. This study also demonstrated that urinary Li 
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clearance and erythrocyte SLC are inversely correlated, thus SLC 
is a marker of renal abnormality and probably the gradual 
development of essential hypertension. In his paper he wrote 
that," Although the mechanisms by which alterations in proximal 
tubular fluid handling related to hypertension are unknown, these 
findings suggest a genetic determinant of renal function that may 
at least partially explain why hypertension "follows the kidney" 
in experimental and clinical renal-transplantation studies" (Weder , 
1986). 
Weinberger et al performed a similar study of normal and 
hypertensive subjects comparing Blacks with Whites (Weinberger 
et aI., 1989). Their results confirmed again that patients with 
established hypertension have higher erythrocyte SLC activity 
than normotensive subjects. The Whites have higher SLC values 
than the blacks. However, contrary to Weder's observation, they 
did not find their hypertensive patients to have a lower renal 
lithium clearance compared to the normal controls. The authors, 
in an effort to untangle the discrepancy between the two results, 
proposed that several factors such as age, body weight, body 
mass index, plasma cholesterol, race, and the influence of genetic 
variance all could have played a role to affect SLC. In Weder's 
study, hypertensive patients had a mean age of 25 years 
compared to 51 years in Winberger's series, which had a lower 
SLC. This was similar to the findings of Brugnara et al who 
showed that SLC correlated inversely with age in a study of SLC 
in normotensive subjects between 10 and 80 years of age 
(Brugnara et aI., 1983). 
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In another study, home blood pressure, invasive systemic 
haemodynamics and two other indexes were measured in 65 white 
men consisting of 23 normotensives, 22 borderline hyper tensive, 
and 20 mild essential hypertensive subjects, SLC activity was 
positively and significantly correlated with home and laboratory 
blood pressure. It was also positively correlated with vascular 
resistance, but not with cardiac output or cardiac index (Weder 
et aI, 1987). 
Duhm and Behr proposed a unifying hypothesis trying to 
link the primary change in plasma lipids to a secondary change 
of the lipid composition of cell membranes which results in 
alterations of lipid-protein interactions within the membrane and 
thereby in alterations of Na transport in red blood cells and some 
other tissues. They found erythrocyte SLC activities rises with 
increasing saturation of the fatty acids in the membrane and, 
combining similar findings of other authors, they postulated that 
alterations of membrane lipids may cause changes of lipid-protein 
interactions at the SLC molecule and thereby alterations of SLC 
rates in essential hypertensive patients (Duhm and Behr, 1987). 
Carr et al concluded that for a "heterogeneous abnormality" 
such as essential hypertension, SLC can not be a reliable 
diagnostic marker, as a large overlap of SLC values in essential 
hypertensives compared with normal controls had been observed 
in most of the related experiments. Their results suggested that 
SLC is only raised in a subgroup of essential hypertensives, in 
which there is a family history of hypertension (Carr et aI., 1988) 
24 
Weder & Schork employed a novel bivariate analytic 
technique, a technique for identifying discrete subgroups within 
populations, to examine the relation of red cell SLC and blood 
pressure in a group of 474 healthy adults. Their results showed 
that increased erythrocyte SLC cosegregates with high blood 
pressure independent of the effects of age, race, gender, body 
weight, or height. In the group with high SLC and h'igh blood 
pressure, a very significant inverse correlation between the two 
variables was observed. This was not seen in the group with 
lower SLC and blood pressure levels. These results support the 
that an elevated erythrocyte SLC in that distinct subgroup of 
hypertensives is a marker of a genetic predisposition to 
hypertension (Weder & Schork, 1989). 
Rutherford et al determined the erythrocyte SLC at 
different extracellular sodium concentration and then calculated 
the maximum velocity and the affinity for sodium on the outside 
of the cell. Their experiments were aimed at defining more closely 
the defect in the SLC to allow a clearer discrimination of the 
patients at risk (Rutherford et aI., 1990). Their results showed 
that there was an increased sodium affinity (lower sodium affinity 
constant) on the outside ion-binding site which boosted SLC 
activity, in those patients with essential hypertension, a positive 
family history but SLC within normal range in the standard assay, 
30% had an increased sodium affinity. A more specific indicator 
than the standard SLC activity assay for a group of patients with 
inherited hypertension is thus a low sodium affinity constant 
(Rutherford et aI., 1990). 
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Curious about whether baseline levels of SLC were 
associated with an increased ris k of hypertension, Hunt e t aI. 
conducted a seven- year prospective study of a cohort of 1,458 
n ormotensive a dults from Utah pedigrees in 1980's. After ana lysis, 
they conclude d that the presence of a major gene for SLC or 
another closely lin ked gene may increase the ris k of hypertension 
developing. High SLC levels do not increase the risk of future 
hypertension for persons whose SLC levels only determined by 
polygenic and environmental effects (Hunt et aI., 1991). 
While most of the investigations in SLC were on adults, 
Norling et a l using the method of Canessa et al (Canessa et at. , 
1980), performed a study on children and adolescents to see if 
SLC could be used as a screening test for hypertensive disease 
(Norling et aI., 1986). Red cell SLC was measured in patients ages 
4-18 years , having essential hypertension or s econdary 
hypertension and compared with normotensive controls. The two 
grou p s were matched for their age, sex, race and weight. The 
results did not differ from that of the adults, they found that 
children and adolescent essential hypertensives had a 
significantly higher red cell SLC rate than the normotensive 
control group; children with secondary hypertension had 
intermediate values not statistically different from values of the 
essential hypertensives or normal controls. No correlation of SLC 
with sex, age and body weight was found in either hypertensive 
or normotensive groups. White normotensive children had 
statistically higher SLC levels than black normotensives. White 
children and adolescents with essential hypertens ion had higher 
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mean SLC than did black hypertensives. However, a large degree 
of overlap of SLC values in the two groups studied was also 
observed (Norling et aI., 1986). 
Weder et al (1991) showed that an elevated V max for 
erythrocyte SLC was associated with a predisposition to future 
hypertension and it was apparently a risk factor which was 
largely independent of other risk factors such as obesity. This 
result did support the necessity of measuring the maximal activity 
of erythrocyte SLC as a way of distinguishing subgroups in the 
population. They also come to the conclusion that a tendency 
toward elevated blood pressure in the high SLC group seemed to 
be lifelong, as the observation revealed an elevation of blood 
pressure in that group as early as age 6. An additional finding 
in their experiment was that they found no evidence to suggest 
a high V max for erythrocyte SLC was connected to a tendency 
toward cardiac and vascular hypertrophy (Weder et ai., 1991). 
1.5.3 SLC in PREGNANCY 
Worley et al were the first to study SLC in Pregnancy 
(Worley et ai., 1982). In their study, they measured SLC in 39 
normal pregnant women, 9 pregnant women with pregnancy-
induced hypertension and 24 normotensive non-pregnant women. 
The mean SLC in normotensive and hypertensive pregnant women 
were O.39±O.02 and O.42±O.04 mmol/hr /L rhc respectively. This 
difference was statistically non-significant. However, if compared 
to the nonpregnant women where mean SLC was O.24±O.06 
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mmol/hr/L rbc, SLC in both normal and hypertensive pregnant 
women were significantly higher. 
In late eighties, Macphail et al studied SLC in 60 
normotensive primigravid women at 6 weekly intervals during 
pregnancy. Amongst these women 9 developed PIH or delivered a 
baby weighing less than the 5th percentile for gestational age. 
They also measured SLC in a group of 39 primigravidae who 
developed PIH in the third trimester. The results showed that SLC 
was significantly elevated during normal pregnancy by 20 weeks 
gestation and did not appear to be as a marker for predicting 
PIH. Amongst the group of 39 primigravidae who developed PIH in 
the third trimester, 26 were classified as proteinuric, and their 
SLC returned to normal soon after labour; in the 13 non-
proteinuric women SLC remained elevated even after delivery. The 
authors believe that this latter group had a predisposition to 
essential hypertension and could possibly help to make a correct 
diagnosis prior to next gestation (Macphail et aI, 1990). 
1.5.4 SLC in OTHER DISEASES 
Two types of diabetes mellitus have been defined. 1. type 
I (insulin dependent) and type 11 (non-insulin dependent). 
However, hindered by obvious difficulty in indicating when the 
disease started and whether any renal involvement is of diabetic 
origin, not much work has been reported on non-insulin 
dependent diabetes mellitus (NIDDM) in regard to SLC. Increased 
SLC has been suggested as a marker for diabetic nephropathy, 
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but with many limited and conflicting findings (Rutherford et aI., 
1992), more investigations, such as careful controlled longitudinal 
studies to ascertain if only uncomplicated diabetic patients with 
elevated SLC develop nephropathy; and family studies to examine 
the link between SLC and hypertension in diabetes need to be 
done. 
There is more work on SLC in regard to insulin-dependent 
diabetes mellitus (IDDM). Mangili et al found that SLC was 
significantly higher in the diabetic patients with renal disease 
than in those without and in non-diabetic patients with renal 
disease. They suggest that an elevated erythrocyte SLC activity 
may serve as a marker for the risk of renal disease in patients 
with insulin-dependent diabetes mellitus (Mangili et aI., 1988) 
Carr et al elaborated further that SLC was increased in 
patients with IDDM before the onset of nephropathy and is 
associated with hyperfiltration, thus elevated SLC activity may be 
an early marker of diabetic nephropathy (Carr et aI, 1990). 
Microalbuminuric insulin-dependent diabetic patients are 
known to be at high risk of progression to clinical nephropathy 
and cardiovascular disease. Jones et al compared erythrocyte SLC 
activity in 36 such patients with that in 36 diabetic patients 
without microalbuminuria. They found that SLC was higher in the 
microalbuminuric than in the control patients. Another finding in 
their study was that patients with diabetic nephropathy had an 
increased incidence of a family history of hypertension in 
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association with abnormal SLC. However, such a familial history of 
hypertension was appraised in the form of questionnaire which 
might lack accuracy (Jones et ai, 1990). 
Rutherford et al (1992) showed a dissimilar kinetic 
mechanism responsible for increased SLC activity in uncomplicated 
diabetes mellitus. Du brey et al examined SLC activity in identical 
twins discordant for type 1 diabetes mellitus and showed a 
significant correlation of SLC between the identical twins; this 
result again supports the that increased SLC activity in type 1 
diabetes is gene-determined (Dubrey et aI., 1991). 
Miilunpalo et al found that SLC was significantly higher in 
obese subjects than in subjects of normal weight and when 
samples from the same su bjects were analyzed once again thirty 
days later, they observed no significant intraindividual 
differences. However they mentioned there existed considerable 
overlap in values between the two groups (Miilunpalo et aI., 1985). 
Corrocher et aI. showed that the maximal rate of SLC was 
significantly higher in hyperlipaemic than in normolipaemic 
patients thus suggesting that the lipid composition of 
erythrocytes influenced the Vmax of SLC (Corrocher et aI., 1987). 
Since the plasma lipids are in a dynamic eq uilibrium with lipid 
components of the red cell membrane, the plasma lipids constantly 
influence the cell membrane composition, membrane ion 
transporters, and membrane physico-chemical properties, such as 
fluidity. SLC, being a membrane transporter, is inevitably affected 
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by a changing of plasma lipids (Corrocher et aI., 1987). 
Adragna et al demonstrated that a three month physical 
training programme can effectively reduce the SLC value in 
normal subjects and patients with essential hypertension. 
Although there was no provision of any statistical correlation, the 
changes in the lipid profile with a rise in HDL cholesterol and no 
alteration in blood pressure all supported the suggestion that 
changes in SLC activity are caused by the changes in plasma 
lipid concentration (Adragna et ai., 1985). 
Investigation of the role of SLC in regard to dyslipidaemia 
in recent years has revealed that a significant decrease of SLC 
activity could be obtained by either undergoing Iow-density 
lipoprotein apharesis (Messner et ai., 1991), or consumption of 
lipid-lowering drugs or through dietary manipulation (Carr et aI., 
1991) . 
Compared to normal subjects, SLC was found to be 
significantly lower in hyperthyroid patients (Arumanayagam et aI., 
1990; Brent et ai., 1990). SLC seem not only to differ between 
species, it varies also in different races of a species. It varies 
also between different races of a species. Arumanayagam and 
associates looked into the differences of SLC between Europeans, 
non- Chinese Asians and Chinese. They found the SLC to be 
higher in Chinese compared to the other two ethnic groups, 
however, no difference was detected between the Europeans and 
non- Chinese Asians (people from the Indian sub-continent) 
31 
(Arumanayagam et aI., 1987). It was also noted that Chinese a nd 
Japanese males had similar SLC values (Arumanayagam et aI. , 1987) 
Blacks have lower SLC than Whites (McDonald et a I. , 1987; Smith 
et aI. , 1988). 
Many factors have also been shown to influence the human 
erythrocyte sodium-lithium countertransport rate. Beuckelmann & 
Erdmann have shown that both those takin g o r al contraceptiv es 
and those who have had chronic hypokalaemia due to abuse of 
diuretic or laxative agents have increased SLC rate. Their 
findings have suggested that SLC is also likely to be hormone -
regulated (Beuckelmann & Erdmann, 1984). Salt intake (Maling & 
Siebers, 1988) have also been reported to alter an individual's 
SLC rate. 
No significant difference in mean adjusted SLC exists 
between men and non-pregnant women (Turner, 1987). No 
differences were detected in pre- and post-prandial sodium-
lithium countertransport rates (Trevisan et aI., 1981), but diurnal 
variation in erythrocyte sodium-lithium countertransport rate, 
which was not related to plasma cortisol concentration, has been 
demonstrated in healthy individuals between 0900h and 2100h, 
with lowest levels at 0900h and highest at 1200h. This 
demonstrates the need for a standardized sampling time in 
epidemiological studies of sodium-lithium countertransport (Sibers 
& Maling, 1990). 
While studying erythrocyte sodium-lithium countertransport 
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in human obesity in a Finnish population, Miilunpalo et al also 
looked into the intra-individual variation of this ionic transport. 
Samples from the same subjects were analyzed again after one 
month interval; no significant differences were observed between 
the two measurements (Miilunpalo et aI., 1985). 
1.6 METHODS USED IN THE STUDY OF ERYTHROCYTE SLC 
Two methods are available for the measurement of sodium-
lithium countertransport. It is either based on saturating the 
internal binding sites of Li (Cannessa et aI., 1980) or of Na (Garay 
et al., 1983). 
In the sodium loading method, nystatin is used to increase 
the Na content to stimulate the SLC maximally. After loading the 
cells with Na by nystatin treatment, the cells are washed 
repeatedly to remove extracellular Na, then the cells are incubated 
in the sodium containing medium (15 mmol/L) to stimulate the SLC 
maximally. 
The Li loading method is that washed erythrocytes are 
incubated at 37°C for 3 hours in a LiCI solution (150 mmol/L) to 
raise the intracellular Li concentration, which must be above 5 
mmol/L, sufficient to stimulate SLC maximally. The Li loaded cells 
are then incubated in NaCI (150 mmol/L) and in choline chloride, 
the difference in the flux rates is SLC (Canessa et aI., 1980; 
Canessa, 1989). 
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Studies (Canessa, 1989) also showed that due to the 
asymmetry of the Li and Na sites on the red cell membrane and 
sensitivity to inhibitors of the anion exchanger like DIDS and 
furosemide, it has shown that measurements of Na-stimulated Li 
efflux is not eq uivalent to Li-stimulated Na efflux; assays of the 
latter may include DIDS-sensitive cation movement coupled to the 
anion exchanger. As such, SLC is best measured as external Na-
stimulated Li efflux. Besides, as external Mg concentration inhibits 
Li efflux into Na-free media, maintaining a steady Mg 
concentration of 1 mmol in the washing and efflux media should 
be strictly followed while the assay is being done. 
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1.7 AIMS OF THE PROJECT 
Several studies have shown that e r ythrocy t e SLC is 
elevated in patients with essential hypertension and in first 
degree normotensive relatives of hypertensive patients. Studies 
on erythrocyte SLC in established PIH have failed to show any 
difference between mean values in subjects wit h PIH and those 
who remained normotensive. It is possible that changes in SLC 
activity in later pregnancy, when the signs of PIH are 
established, may obscure any hereditary predisposition for 
developing the condition. At present, none of the techniques used 
in the prediction of PIH are suitable or effective for screening 
large numbers of subjects (Section 1.4). 
The aim of the project was to determine the precision for 
the measurement of erythrocyte SLC and to determine the intra-
individual variation in healthy males and females. Moreover, 
erythrocyte SLC activity was to be determined in second and 
third trimesters of pregnancy in a cohort of primigravid women , 
I 
before the development of clinical signs of PIH in order to ~I 
I 




MATERIALS & METHODS 
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2.1 Anthropometric Measurements 
2.1.1 Blood Pressure Measurements 
The 8100 portable DinamapTM non-invasive vital signs 
monitor, model number 1846 SX/P (Critikon, Inc., Tampa, FL 33630 
U.S.A.) was used in taking the blood pressure throughout the 
entire project. This equipment performs non-invasive measurement 
of blood pressure and heart rate by the oscillometric stepped 
deflation method, which rejects artifacts from patient movement 
and external interference such as external transducers or 
microphones. 
2.1.2 Physical Measurements 
Body measurements such as height and weight were all 
carried out on the same instruments throughout the entire project 
to ensure steadiness in measuring. 
2.1.3 Gestational Age 
The expected date of delivery is seven days and 9 months 
after the first day of the last normal menstrual period. This is 
the standard way to calculate gestational age. However, as not all 
women can recall exactly the first day of their menstrual flow, 
sometimes symptoms and signs of early pregnancy, as well as 
ultrasonography have to be used in order to determine gestational 
age more accurately. All of the patients in this . study had their 
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gestational age confirmed by ultrasound before 26 weeks. 
2.2 Materials 
D-Glucose (anhydrous) and Sodium Chloride of 'AnalaR' 
grade were purchased from BDH Chemical Co., PooIe, Dorset, U K. 
Magnesium Chloride (MgCI2 06H 20), of 'G R ' grade, was bought 
from Merck, Darmstadt, Germany. Lithium Standard Solution was 
obtained from Wako Pure Chemical Industries, Ltd., Osaka, Japan. 
Tris (Tris[hydroxymethyl] amino-methane), ouabain (octahydrate) , 
lithium chloride (anhydrous), choline chloride, and MOPS (3- [N-
Morpholino] propanesulfonic acid) were products of Sigma Chemical 
Co., St. Louis, MO, U.S.A. ChemTRAK™ Liquid Unassayed Chemistry 
Control, Level 1 & level 3 were acquired from Medical Analysis 
systerns, Inc. , Camarillo, U. S. A. 
2.3 Method for the Measurement of Erythrocyte SLC 
The rationale of this method is based on the observation 
that efflux of lithium from lithium loaded red blood cells into 
sodium-containing and sodium-free medium is a measure of the 
S LC activity. 
All glassware and plastic tubes were washed with dilute 
HN0 3 (20% v Iv) and rinsed six times with distilled deionised water. 
Following solutions were prepared and stored at 4°C. 
Solutions 






















































Ouabain (0.1 mITlol/L) 
The procedure is as follows: 
Venous blood (10 ml) collected in lithium heparin tubes was 
centrifuged at 500g for 10 minutes in a Heraeus Christ 
(DigifugeGL) centrifuge at room temperature. After removing and 
discarding the plasma and buffy coat, the red blood cells were 
washed twice with excess choline washing solution. A Venturi 
pump was used to aspirate and discard the supernate. Four parts 
of the lithium loading solution was then added to one part of the 
washed cells. The cell suspension was transferred to a 100 ml 
Erlenmeyer flas k for incubation for three hours at 37°C in a 
shaking water bath (80 Os/min). After incubation, the mixture was 
transferred to a universal container and centrifuged for 5 
minutes at 500g. The supernatant was discarded and the red cells 
washed four times with excess choline washing solution containing 
ouabain. After the final wash, the red blood cells were 
resuspended in the same solution at a packed cell volume (PCV) 
of 20-25% and kept on ice. The pev of this suspension was 
determined by the microhaematocrit method. 
Two sets of tubes were prepared and labelled. 2 ml of 
sodium-free medium or sodium-containing medium was added to 
the tubes and kept in an ice water bath. An aliquot (0.5 ml) of 
the red blood cell suspension was added to each tube, mixed well 
and capped. All tubes were transferred to a water bath at 37°C 
at time zero and incubated for 10, 30, and 60 minutes. Following 
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incu bation, they were transferred to an ice/water bath for 1 
minute before centrifuging at 4° C for three minutes. The 
supernatant (2 ml) was aspirated from each tube and transferred 
to another set of plain tubes. Lithiu rTl in the s upernatant was 
deterrnined by flame atomic absorption spectrometry (Varian 
Techtron Pty Ltd., Melbourne, Australia, Model AA-1475) using 
Lithium standards prepared in either sodium-containing medium 
or sodium-free medium as appropriate. 
The intracellular Lithium concentration of lithium loaded 
cells was measured by adding 0.1 ml of red blood cells suspension 
to 4.9 ml of distilled water. Li was determined by flame atomic 
absorption spectrometry using standards prepared in distilled 
water. 
ChemTRAK 1 and ChemTRAK 3 diluted in sodium-containing 
and sodium-free medium were used as quality control material 
during the measurement of lithium by atomic absorbtion 
spectrometry. 
For each of the incubation (i.e. in sodium-containing or 
sodium-free medium), a regression line of lithium concentration in 
the supernatant was plotted against time and the coefficient of 
regression calculated. The rate of efflux of lithium (umol Li/hr /L 
rbc) was calculated using the formula: 
Rate of efflux of Li 
-3 
= A x [2.5-0.5 xPCV] x10 ;0.5 xPCV 
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where 2.5 is the total volume of the incubation mixture (ml), 
0.5 is the volume and PCV is the packed cell volume of the lithiurn 
loaded red blood cell suspension. 
SLC was derived from the difference in the efflux rates 
between sodium-containing and sodium-free media. 
CHAPTER 3 
PRECISION & INTRA-INDIVIDUAL VARIATION OF 
ERYTHROCYTE SLC IN MALES AND FEMALES 
42 
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3.1 Assessment of the Precision of the Methods 
Assessment of the precision of a method is usually by 
replicate determination of samples and by determining the mean 
and standard deviation of the estimates. When the standard 
deviation is divided by the mean, the quotient is the coefficient 
of variation which is a measure of the precision of the method. In 
circumstances in which there is insufficient material for multiple 
analyses, the precision can then be determined by assaying a 
sufficient number of specimens in duplicate and calculating the 
difference (d) between the duplicates. Thus the standard 
deviation of a series of duplicates can be calculated as: 
where N stands for the number of duplicates. 
The analytical coefficient of variation of the method is the 
analytical standard deviation divided by the mean result of all the 
specimens (Broughton; 1978). 
Specimens from 24 male and female subjects were assayed 
in duplicate, the standard deviation of the duplicates was 




Precision of the Measurement of Erythrocyte SLC 
Mean SD Analytical CV N 
681 42 6.2 24 
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3.2 Method of Study 
a. Females 
A group of 10 healthy Chinese women with a median age of 
39 (23-47) was recruited. They were studied both in the luteal 
phase and the follicular phase. This was done so by collecting 
venous blood on the 7-10th days after the first day of last 
menstrual period and 7-10 days before the next period. The 
laboratory procedure was as mentioned in chapter 2.3, except that 
an extra 2 ml of clotted blood was required for the measurement 
of progesterone and oestradiol each time. Serum progesterone and 
oestradiol were determined by radioimmunoassay using commercial 
kits obtained from Diagnostic Products Corp. (Los Angeles, CA, 
U.S.A.). 
b. Males 
A total of 5 healthy reproductive males with a median age 
of 36 were recruited. Each of them was studied 4 times, at times 
0, 4, 8 and 28 weeks, respectively after the first blood taking. 
The laboratory procedure was as described in section 2.3. 
Subjects were excluded from the study if they; 
1. were taking oral contraceptives or any other medication. 
2. had a family history of hypertension or carriers of 
thalassaemia. 
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3. were lactating or were pregnant. 
3.3 Statistics 
Because it was not possible to ascertain departures from 
Gaussian distribution due to a small number of subjects or when 
the results were not normally distributed (chapter ' 4), non-
parametric statistics were used to analyse the data throughout 
the study. Results are given as median & range. Mann-Whitney U-
test was used to compare two groups of subjects and Wilcoxon's 
signed rank test was used to assess paired data. Kruskal-Wallis 
One Way Analysis of Variance was used to analyse three or more 
R groups of subjects. The Abstat statistical programme on a 
personal computer was utilized for all the calculations. 
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3.4 Results 
The ages, systolic and diastolic blood pressures, serum 
progesterone and oestradiol concentrations in two different 
menstrual cycles are shown in table 3.2. Erythrocyte SLC values 
are shown in table 3.3 and in figure 3.1. 
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Table 3.2 
Age , Blood Pres s ure, Serum Progesterone & Oestra diol in 




Systolic BP 120 115 NS 
(mmHg) (100-140) (100-120) 
70 70 NS 
Diastolic BP (70-80) (70-80) 
(mmHg) 
Progester one 0.7 19.65 
*** (nmol/L) (0.3-3.8) (0.7-47.2) 
Oestradiol 150 212 NS 
(pmol/L) (90-370) (98-374) 
*** P<O.OOl ,NS no slgnlflcant dlfference by Mann-Whltney o-tes t 
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Table 3.3 
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There was no significant difference in the systolic or 
diastolic blood pressures or serum oestradiol concentrations 
between the follicular and luteal phases. Serum progesterone 
concentration was significantly higher in the luteal phase 
compared to follicular phase (table 3.2). Erythrocyte SLC was 
however, was similar in the follicular and luteal phases of the 
menstrual cycle (table 3.3 & fig 3.1). 
Table 3.4 and figure 3.2 shows the erythrocyte SLC values 
in 5 healthy males. There was no difference in the erythrocyte 




SLC Measurements in 5 Males at Different Time Periods 
AGE SLC * SLC SLC SLC 
(Owks) (4wks) (8wks) (28wks) 
A 40 347 312 277 311 NS 
B 34 328 414 250 322 NS 
C 36 200 225 330 357 NS 
D 34 747 744 657 795 NS 
E 30 191 375 222 266 NS 
* 
umol/hr/ L rbe 
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PREDICTION OF PREGNANCY-INDUCED HYPERTENSION: 
SLC ACTIVITIES IN SECOND & THIRD TRIMESTERS 
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4.1 Method of the Study 
All the subjects recruited in the study were of Chinese 
origin , being primigravidae and free of a family history of 
hypertension. 63 subjects were studied at second trimester , 90 
subjects were studied at third trimester and 35 subjects were 
studied at both trimesters. 
A DinamapTM non-invasive vital sIgns monitor was used to 
measure systolic, diastolic and mean arterial pressure. Subjects 
were required to rest for 30 minutes before the blood pressure 
measurement, a further 5 minutes rest was allowed before venous 
blood was collected into lithium heparin tubes for the 
determination of red cell SLC (section 2.3). Spot urine specimen 
were also collected an d were tested for significant proteinuria 
(>300mg/L) using Multistix (>1+). 
The subjects were regularly followed-up until delivery. PIH 
was diagnosed if a pregnant women had conformed to the criteria 
set up by Redman & Jefferies (refer to Section 1.1, the revised 
definition). The subjects were divided into 3 groups on the basis 
of the following criteria. These were: 
1. Normotensive 
2. Non-proteinuric (gestational) Hypertensive 
3. proteinuric hypertensive (PET) 
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4.2 Results 
Table 4.1 shows the number, their ages, gestational ages 
and the mean arterial pressures of the subjects who were studied 
in second and third trimesters. Of the 63 subjects studied in the 
second trimester, 12 subjects developed PIH and of the 90 
subjects studied in the third trimester, 13 subjects ' developed 
PIH. 
There was no significant difference in the ages, gestational 
ages or the mean arterial pressures at either trimester between 
those who developed PIH and those remained normotensive. 
Table 4.2 shows the red cell SLC activity determined in the 
above-mentioned subjects. In the second and third trimesters, the 
subjects who had developed PIH had a similar range of values to 
those who remained normotensive. 
Table 4.3 provides the data on subjects who were studied 
in both trimesters. Thirty five subjects remained normotensive 
and 8 subjects developed PIH. 
There was no significant difference in the mean arterial 
pressures in the two groups of subjects. Erythrocyte SLC 
however, significantly increased with increasing gestational age 
in both groups of subjects. The degree of rise in erythrocyte 
SLC was similar in both groups of subjects. 
57 
The subjects who developed PIR were subdivided on the 
basis of urinary excretion of protein. Figures 4.1 and 4.2 shows 
the SLC activities of pregnant women studied in the second and 
third trimesters, respectively . 
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Table 4.1 
Age, gestational age and mean arterial pressures of the subjects 
in the study; comparison between those who remained 
normotensive and those who developed PII-L 
NT PIH 
2nd Trimester 
Number 63 13 
Age 27 27 NS 
(yrs) (19-35) (18-35) 
Gestational Age 22 23 NS 
(wks) (17-24) (19-24) 
Mean Arterial Pressure 69 75 NS 
(mmHg) (50-93 ) (63-87) 
3rd Trimester 
Number 90 12 
Age 27 27 NS 
(yrs) (20-35) (18-35) 
Gestational Age 32 31 NS 
(wks) (25-35) (25-34) 
Mean Arterial Pressure 68 71 NS 
(mmHg) (53-93) (63-87) 
NS no significant difference by Mann-Whitney U-test 
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Table 4.2 
Erythrocyte SLC activity of the subjects who remained 
normotensive and those who developed PIR. 
2nd Trimester 
Number 
SLC (umol/hr/L rbc) 
3rd Trimester 
Number 















* NS no significant difference between NT & PIR in two trimesters 
by Mann-Whitney U-test 
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Table 4.3 
Erythrocyte SLC activity in both groups of subjects who were 
studied at both 2nd and 3rd trimesters of pregnancy 
2nd Trinlester 3rd Trimester 
Normotensives 
Number 35 35 
Age(wks) 28 
(22-35) 
Gestational Age 22 31 
(wks) ( 18-26) (29-34) 
MAP 67 69 NS 
(mmHg) (50-93) (50-93) 
SLC 260 399 *** (umol/hr/L rbc) (91-825) (91-940) 
Number 8 8 
Age(yrs) 27 
(18-35) 
Gestational Age 23 31 
( (wks) (19-24 ) (29-34) 
MAP 75 71 NS 
(mmHg) (63-87) (63-87) 
SLC 308 467 *** 
(umol/hr/L rbc) (71-648) (144-895) 




SLC Activity in 2nd Trimester 
1000 





"'- 600 • ~ 
.c 0 
"'- 0 • 0 6 9 • A E 400 • 
:J 8 6 ............ 
@ • U 
-1 




0 1 2 3 
Normotensive Non - Protein uric Proteinuric 
Hypertensives H y pert ens i v e s 
62 
FIGURE 4.2 





..0 0 • L 
-1 0 













0 1 2 .3 







The method used for the measurement of erythrocyte 
SLC measures activity in a standard assay with non-saturating 
external sodium concentration but at a saturating internal lithium 
concentration (Canessa, 1989). The precision of the method as 
assessed by measuring duplicate samples and then calculating the 
analytical CV was about 6%. This is similar to the earlier finding 
of analytical CV of about 5% from this (Arumanayagam et aI, 1987) 
and other laboratories (Canessa, 1989). Intra-individual variation 
remained unchanged over a 28 week period. This is in agreement 
with the earlier observations (Smith et aI., 1982; Miilunpalo et ai., 
1985) that erythrocyte SLC is a stable biochemical index over a 
long period of time. 
In the study of the effect of menstrual cycle on 
erythrocyte SLC, a normal range for non-pregnant Chinese women 
has been established. No significant difference in SLC values 
between the two menstrual phases was observed. Comparing 
progesterone and oestradiol concentrations in the two phases, 
differences in the latter were found to be not significant. 
However, the progesterone concentration was significantly higher 
in the luteal phase compared to the follicular phase. This is in 
accord with the fact that in each menstrual cycle, there are two 
peaks for oestrogen 'secretion but only one peak for progesterone 
secretion which is in the luteal phase. 
In comparison with the findings of Turner et al in 
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Caucasian women, a similar SLC value has been observed (Turner 
et ai., 1989). This result does not parallel with the findings of 
Arumanayagam et al which demonstrated a significant difference 
of SLC between European and Chinese males (Arumanayagam et ai., 
1987). We expect that females of the two races should have a 
dissimilar SLC value like their male counterparts. This 
discrepancy is may be due to the differences in the methodology 
used in this study and that of Turner et ai., (1989). Turner et al 
employed the method of Canessa with minor modifications 
described by Smith et al which is not similar to this study. 
Examination of the concentration used in the two experiments has 
also revealed some differences. Turner el al used a higher 
concentration of MgCl2 of 75 mmol/L, and a 85 mmol/L of sucrose 
concentration compared to this study where the MgCl2 
concentration was 1 mmol/L. Another possible factor is the age of 
the subjects, the mean age in this study was 39 with a range of 
23-47. In Turner's study, a mean age was derived from the means 
of ,three different groups, age-oriented these groups were 20-
29.99, 30-39.99, and 40-49.99 years old respectively. The mean SLC 
of 265 mmol/hr /L rbc was also derived from the means in these 
three groups, they were 253.8, 262.8, and 278.8 mmol/hr/L rbe. A 
minor difference between reported blood pressures (107/64 mmHg 
for Turner et al and 118/70 mmHg for this study does not look 
sufficiently large to offer an explanation. 
SLC is affected by pregnancy (Worley et ai., 1982; Macphail 
et ai., 1990). Worley et al (1982) showed that normotensive 
pregnant subjects had increased erythrocyte SLC values when 
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compared to normotensive non pregnant subjects. However , there 
\vas no s ignificant difference in the SLC values bet ween those 
pregnant subjects with established h ypertension compared to 
normotensive pregnant subjects CWorley e t aI, 1982). A 
longitudinal study by Macphail and co workers (1990) s howed that 
in normal human pregnancy, SLC activity rises with the Inajor 
increase occurring in the first trimester and is then maintained 
until 38 weeks; post partum, the SLC activity fell. In their study, 
sodium-lithium countertransport activity was determined in 60 
normotensive primigravid women at 6 weekly intervals during 
pregnancy, nine of whom developed PIH or delivered a baby less 
than the 5th percentile for gestation and were thus being studied 
separately. Comparison of the corresponding SLC activity of the 
two groups at 14th, 20th, 26th, 32th, 38th and 20 weeks afte r 
delivery were made, however no significant difference was 
observed between those who developed PIH and those who 
remained normotensive (Macphail et aI., 1990). Rutherford et al 
(1992) compared the sodium affinity (Km) at the external site of 
the countertransporter and maxiInum velocity (V max) of SLC in 15 
women with a normal pregnancy and 14 primigravidae whose 
pregnancies were complicated by hypertension. They found that 
the mechanism of increased sodium-lithiunl countertransport in 
normal pregnancy is due to an increased maximum velocity (VIllc'l.x) 
for sodium with the sodium affinity (Km) remaining unchanged. In 
14 subjects who developed hypertension, the mean activity was 
similar to the normotensive group. However, six subjects had 
increased affinity for sodium (Km) suggestive of essential 
hypertension (Rutherford et aI, 1992). 
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I n this study, only primigravid wonlen were recruited in 
order to select only subjects at risk of developing PIR where no 
underlying disease was evident. The subjects were followed up 
until delivery. Sixty three women were studied in the second 
trimester and 90 women were studied in the third trimester. Of 
the women who were studied in the second trimester, 13 
developed PIR. Their ages, gestational ages, mean arterial 
pressures and SLC were similar to those who remained 
normotensive at the time of study. Similarly, of the 90 women 
who were studied at in the third trimester, 12 developed PIR. The 
percentage of women who developed PIR is therefore between 13-
22%. This value is similar to that reported from other centres for 
primigravid women (section 1.3). 
All the erythrocyte SLC measurements were made before the 
onset of hypertension to evaluate the effectiveness of using SLC 
in the prediction of PIR. Other predictors of PIR (section 1.4) 
have all been shown to have poor predictive value when 
screening large numbers of subjects. Erythrocyte SLC is a 
relatively easy technique to screen large numbers of subjects. A 
total of 153 subjects were screened in this study. 
There was however, no difference in the SLC values 
between those subjects who remained normotensive and those who 
developed PIR, in either trimester. Comparison of SLC activity 
between protein uric and non-proteinuric hypertensives also 
revealed no significant difference at either trimester. These 
observations demonstrate that erythrocyte SLC is not a predictor 
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of PIH. Although, erythrocyte SLC has been shown to be useful 
marker in essential hypertension (section 1.5.2), this study 
suggests that the mechanism and pathophysiology of PIH is 
different from that of essential hypertension. 
In conclusion, the normal range of SLC values in the 
Chinese females was established and its activity was shown to be 
not affected by cyclical hormonal changes. In males, SLC activity 
was stable over a period of 28 weeks. 
In the case of primigravid women, erythrocyte SLC activity 
rose with gestational age. When the SLC measurements were made 
before the onset of signs and symptoms of PIH, there was no 
significant difference in the SLC values in the subjects who 
subsequently developed PIH and those who remained normotensive. 
Erythrocyte SLC thus has no value as a predictor of PIH in 
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